We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Brolucizumab (rbe)
Australian Public Assessment Report
Device/Product Name
Beovu
Active ingredients
Brolucizumab (rbe)
AusPAR Date
Published
Submission Number
PM-2019-00106-1-5
Submission Type
New biological entity
Decision
Approved